Evidence map›Paper›PMID 34289801›Full record

ArticleBMC infectious diseases2021

Seroprevalence of hepatitis B virus infection, anti-HCV antibodies and HIV and knowledge among people who use drugs attending methadone therapy clinic in Tanzania; a cross-sectional study.

Semvua B Kilonzo, Daniel W Gunda, David C Majinge, Hyasinta Jaka, Paulina M Manyiri, Fredrick Kalokola, Grahame Mtui, Elichilia R Shao, Fatma A Bakshi, Alex Stephano

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Semvua B KilonzoDepartment of Medicine, Catholic University of Health and Allied Sciences, P.O Box 1464, Mwanza, Tanzania. sekipcb@yahoo.com.ORCID http://orcid.org/0000-0003-1197-9368
Daniel W GundaDepartment of Medicine, Catholic University of Health and Allied Sciences, P.O Box 1464, Mwanza, Tanzania.
David C MajingeDepartment of Medicine, Catholic University of Health and Allied Sciences, P.O Box 1464, Mwanza, Tanzania.
Hyasinta JakaDepartment of Medicine, Catholic University of Health and Allied Sciences, P.O Box 1464, Mwanza, Tanzania.
Paulina M ManyiriDepartment of Medicine, Catholic University of Health and Allied Sciences, P.O Box 1464, Mwanza, Tanzania.
Fredrick KalokolaDepartment of Medicine, Catholic University of Health and Allied Sciences, P.O Box 1464, Mwanza, Tanzania.
Grahame MtuiDepartment of Medicine, Sekou Toure Regional Referral Hospital, P.O Box 132, Mwanza, Tanzania.
Elichilia R ShaoDepartment of Medicine Kilimanjaro Christian University College, P.O Box 2240, Moshi, Tanzania.
Fatma A BakshiDepartment of Medicine, Aga Khan Hospital, P.O Box 2289, Dar es Salaam, Tanzania.
Alex StephanoDepartment of Medicine, Catholic University of Health and Allied Sciences, P.O Box 1464, Mwanza, Tanzania.
Catholic University of Health and Allied Sciences · TZAga Khan Hospital Dar es Salaam · TZKilimanjaro Christian Medical Centre · TZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMethadone therapy clinics have been recently introduced in Tanzania, aiming at reducing risk behaviors and infection rates of viral hepatitis and HIV among people who use drugs. The objective of this study was to estimate the prevalence, associated factors and knowledge level of these conditions among people who use drugs attending a methadone clinic in Tanzania.

methodsWe enrolled 253 People who using drugs receiving Methadone therapy. Clinical data was retrospectively collected from the medical records and face-to face interviews were conducted to determine the behavioral risk factors and respondents' knowledge on viral hepatitis and HIV.

resultsAn overall seroprevalence of viral hepatitis (either hepatitis B surface antigen or anti-hepatitis C virus) was 6.3%, while that of hepatitis B virus mono infection was 3.5% and anti-hepatitis C antibodies was 3.5%. Seroprevalence of HIV was 12.6%. Viral hepatitis was strongly predicted by advanced age (> 35 years) (p = 0.02) and staying at Kirumba area (p = 0.004), and HIV infection was predicted by increased age (> 37 years) (p = 0.04) and female sex (p < 0.001). Regarding the knowledge of viral hepatitis, majority of the respondents were unaware of the transmission methods and availability of hepatitis B virus vaccines and only 17% were classified as well informed (provided ≥4 correct answers out of 7 questions). Good knowledge was highly predicted by higher education level of the individual (p = 0.001).

conclusionsDespite the efforts to curb viral hepatitis and HIV infections through Methadone clinics, infection rates among people who use drugs are still high and the general knowledge on preventive measures is inadequate.

Indexed as

Health Knowledge, Attitudes, PracticeAdolescentAdultAmbulatory Care FacilitiesCross-Sectional StudiesDrug UsersFemaleHepatitis BHepatitis CHepatitis C AntibodiesHIV InfectionsHumansMaleMethadoneMiddle AgedRetrospective StudiesHepatitis C AntibodiesMethadoneHIVPeople who use drugsTanzaniaViral hepatitis

Identifiers

PMID34289801
PMCPMC8296674
OpenAlexW3183978298

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.